OncoDaily, a specialized and peer-reviewed oncology news platform, has released a compilation titled '10 Must-Read Posts in GI Oncology This Week,' published on January 12, 2026. This curated collection focuses on translational and practice-shaping discussions in gastrointestinal (GI) oncology, spanning fundamental cancer biology, biomarker-driven decision-making, real-world evidence, and evolving multidisciplinary strategies. The articles emphasize that advancements in GI oncology increasingly rely on a comprehensive understanding of tumor biology, patient fitness, disease dynamics, and precise timing, moving beyond single markers or isolated interventions. Key themes include neoadjuvant immunotherapy in colon cancer, ctDNA-guided adjuvant decisions, organ-sparing approaches in gastric cancer, and liver transplantation for colorectal liver metastases. Additionally, OncoDaily provides context through related articles such as 'Inside ASCO GI 2026 with Mark Lewis.' The American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026 is confirmed to take place from January 8 to 10, 2026, at Moscone West in San Francisco, CA, with virtual participation options. Dr. Mark Lewis, Director of Gastrointestinal Oncology at Intermountain Healthcare, is a highly respected medical oncologist specializing in GI tract cancers, young-onset cancers, and hereditary cancer syndromes. His involvement in discussions surrounding ASCO GI 2026 lends significant credibility to the anticipated insights, given his active role in clinical research and the American Society of Clinical Oncology. The news highlights the global nature of GI oncology advancements, making it highly relevant for an Indian audience seeking updates on cutting-edge cancer research and treatment strategies worldwide.